毕得医药(688073.SH)：董事长、总经理戴岚拟减持不超过14.88万股

Core Viewpoint - Bid Pharma (688073.SH) announced that its controlling shareholder, actual controller, and company chairman and general manager, Ms. Dai Lan, plans to reduce her shareholding due to personal funding needs, with a maximum reduction of 148,800 shares, accounting for 0.16% of the company's total share capital [1] Summary by Sections - Shareholding Reduction Plan - Ms. Dai Lan intends to reduce her shareholding through centralized bidding transactions starting 15 trading days after the announcement, within a period of three months [1] - The maximum number of shares to be reduced is 148,800, which represents 0.16% of the total share capital of the company [1] - The reduction price will be determined based on the market price at the time of the actual implementation [1]